Broadview Advisors’s Pediatrix Medical MD Stock Holding History

Broadview Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-72,275	Closed	-$2.38M	–	99
2018 Q4	$2.38M	Sell	72,275 -71,750	-50%	-$2.88M	0.69%	51
2018 Q3	$6.72M	Buy	144,025 +109,300	+315%	+$5.02M	1.15%	41
2018 Q2	$1.5M	Sell	34,725 -52,700	-60%	-$2.53M	0.24%	79
2018 Q1	$4.86M	Buy	87,425 +9,550	+12%	+$523K	0.8%	63
2017 Q4	$4.16M	Buy	77,875 +625	+0.8%	+$29.5K	0.59%	68
2017 Q3	$3.33M	Buy	+77,250	New	+$3.67M	0.49%	69

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Broadview Advisors's MD Position: Q1 2019 in Review

Broadview Advisors sold out of Pediatrix Medical (MD) in Q1 2019, closing a stake of 72,275 shares — an estimated $2.38M sold.

Broadview Advisors first reported a position in MD in Q3 2017 and held it in 6 quarters. The position peaked at $6.72M in Q3 2018. 297 funds tracked by Wall St. Rank hold MD as of Q1 2019.

Broadview Advisors reported no remaining Pediatrix Medical position as of Q1 2019 after selling out during the quarter.
Broadview Advisors sold 72,275 Pediatrix Medical shares in Q1 2019, an estimated $2.38M.
Broadview Advisors first reported a position in Pediatrix Medical in Q3 2017 and held it in 6 quarters.
Broadview Advisors's Pediatrix Medical position peaked at $6.72M in Q3 2018.
297 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2019.

Based on Broadview Advisors's 13F filing for Q1 2019, filed 15 May 2019.